Molecular Therapy Nucleic Acids

Mol Ther Nucleic Acids

2162-2531

Therapeutic Area

Biotechnology, Cytology/Cell Biology, Genomics, Research

Bioengineers, Biomedical Engineers/Technologists, Biomedical Researchers, Cell Biologists, Clinicians, Cytologists/Cell Biologists, Organic Chemists, Researchers

Molecular Therapy Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic-acid-based therapeutics to treat and/or correct genetic and acquired disease. As an official journal of the American Society of Gene & Cell Therapy, Molecular Therapy Nucleic Acids builds upon the success of Molecular Therapy in publishing important peer-reviewed research, cutting-edge reviews, and commentaries targeted to advances in gene- and oligonucleotide-based therapies. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials.

American Society of Gene & Cell Therapy (ASGCT)

Cell Press

Impact Factor JCR Categories/Rank Submission to Acceptance Acceptance to Online Publication Frequency Author Submission Guidelines